SWOG clinical trial number
E1395
A Randomized Phase III Evaluation of Paclitaxel + Cisplatin Versus Cisplatin + 5-FU in Advanced Head and Neck Cancer
Closed
Phase
Published
Abbreviated Title
A Randomized Phase III Evaluation of Paclitaxel + Cisplatin Versus Cisplatin + 5-FU in Advanced Head and Neck Cancer
Activated
04/01/1999
Closed
01/12/2000
Publication Information Expand/Collapse
2005
Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an Intergroup trial of the Eastern Cooperative Oncology Group
2002
Quality of life and pain assessment for head and neck cancer patients treated on E1395: a comparison of two different cisplatin-based chemotherapy regimens.
2001
Phase III study comparing cisplatin (C) & 5-flurouracil (F) versus cisplatin (C) & paclitaxel (T) in metastatic/recurrent head & neck cancer (MHNC).